Previous 10 | Next 10 |
MALVERN, Pa., Sept. 28, 2023 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (the “Company” or “Baudax Bio”) (NASDAQ: BXRX), a biotechnology company focused on developing T cell receptor (“TCR”) therapies utilizing human regulatory T cells (“Tregs”), a...
MALVERN, Pa., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (the “Company” or “Baudax Bio”) (NASDAQ: BXRX), a biotechnology company focused on developing T cell receptor (“TCR”) therapies utilizing human regulatory T cells (“Tregs”), a...
2023-09-06 06:59:17 ET More on Baudax Bio Seeking Alpha’s Quant Rating on Baudax Bio Historical earnings data for Baudax Bio Financial information for Baudax Bio Baudax Bio announces $1.9M registered direct offering priced ATM For further detai...
2023-08-17 08:33:07 ET More on Baudax Bio Baudax Bio stock dips on pricing $4M stock offering at $1.15/share Baudax Bio stock surges ~40% as neuromuscular blocker BX1000 shows promise in trial Baudax rises after mid-stage data for neuromuscular blocking agent ...
MALVERN, Pa., Aug. 17, 2023 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (the “Company” or “Baudax Bio”) (Nasdaq: BXRX), a biotechnology company focused on developing T cell receptor therapies utilizing human regulatory T cells, as well as a portfolio of clinical stage Neuromu...
2023-08-16 13:49:05 ET Baudax Bio press release ( NASDAQ: BXRX ): GAAP EPS of -$1.49 beats by $0.55 . As of June 30, 2023, Baudax Bio had cash and cash equivalents of $1.4 million. For further details see: Baudax Bio GAAP EPS of -$1.49 beats by $0.55
Transformative Period Led by Acquisition of TeraImmune Company to Prioritize Development of New TI-168 Treg Asset for Hemophilia A Continuing to Advance Neuromuscular Blockade (NMB) Portfolio at Modest Pace Announcement of Positive Top-Line Results from Phase 2 BX1000 Tr...
2023-07-05 06:00:00 ET 3 Tips for Understanding Breakout Patterns With Penny Stocks Trading penny stocks can be an exciting and profitable endeavor for those who understand the game. Among the various strategies used by traders, one of the most intriguing is the identification of breako...
2023-07-03 08:22:42 ET Baudax Bio ( BXRX ) -13% . VBI Vaccines ( VBIV ) -12% . Addentax Group ( ATXG ) -10% . AstraZeneca PLC ( AZN ) -7% . TOP Financial Group Limited ( TOP ) -4% . For further details see: AZN and VBIV amo...
2023-07-01 11:16:00 ET 3 Tips for Analyzing Penny Stocks Charts Like a Pro Navigating the world of penny stocks—those enticing equities trading at less than $5 per share—can be a rewarding yet complex endeavor. The high volatility that characterizes these assets offers uni...
News, Short Squeeze, Breakout and More Instantly...
Baudax Bio Inc. Company Name:
BXRX Stock Symbol:
NYSE Market:
Evolv Technologies Holdings Inc. (EVLV) is expected to report $-0.14 for Q4 2023 The Lion Electric Company (LEV) is expected to report $-0.1 for Q4 2023 Fisker Inc. Class A (FSR) is expected to report $-0.2 for Q4 2023 Y-mAbs Therapeutics Inc. (YMAB) is expected to report $-0.19 for Q...
Laser Photonics Corporation (LASE) is expected to report for Q2 2024 QuickLogic Corporation (QUIK) is expected to report $0.08 for Q3 2023 Stryve Foods Inc. (SNAX) is expected to report $-1.65 for Q3 2023 Reata Pharmaceuticals Inc. (RETA) is expected to report $-2.15 for Q3 2023 V...
Baudax Bio Inc. (BXRX) is expected to report $-0.53 for Q3 2023